CD4 and lung carcinoma: The GSVA assay revealed that the top 100 gene set highly expressed in GZMA CD4 T cells was associated with better overall survival in LUAD patients, suggesting that the presence of GZMA CD4 T cells may provide potential benefits for lung cancer patients (Figure 5E, sTable 2).